U.S. federal trademark · Serial No. 79324421 · Reg. No. 7014602
Pharmaceuticals, namely, small molecules therapeutic preparations for the regulation of mRNA translation and mRNA biology, used in the treatment of fibrosis, cancers, neurological diseases, infectious diseases, genetic diseases, and other diseases; pharmaceutical and medical preparations and substances for the treatment of fibrosis, cancers, neurological diseases, infectious diseases, genetic diseases, and other diseases; medical and pharmaceutical chemical preparations for the treatment of fibrosis, cancers, neurological diseases, infectious diseases, genetic diseases, and other diseases; pharmaceutical preparations for RNA targeted therapeutics; therapeutic agents for acting on protein targets that regulate translational control of gene expression
Research and development of pharmaceuticals, namely, small molecule therapeutic preparations for the regulation of mRNA translation and mRNA biology, used in the treatment of fibrosis, cancers, neurological diseases, infectious diseases, genetic diseases, and other diseases; research and development of pharmaceutical preparations; pharmaceutical drug development services; providing scientific research information in the field of pharmaceuticals and molecular biology; research, analysis, and development in the field of pharmaceutical; research and development in the field of bio-therapeutics for the treatment of fibrosis, cancers, neurological diseases, infectious diseases, genetic diseases, and other diseases; scientific investigations for medical purposes; pharmaceutical, medical and scientific research, and development; drug development and discovery; scientific and technological services and research relating to the field of pharmaceuticals
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.